Los Angeles Capital Management’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $10.3K | Buy |
|
|||||
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $453K | Sell |
|
|||||
|
2024
Q3 | $814K | Sell |
|
|||||
|
2024
Q2 | $1.23M | Sell |
|
|||||
|
2024
Q1 | $1.14M | Buy |
|
|||||
|
2023
Q4 | $999K | Buy |
|
|||||
|
2023
Q3 | $949K | Buy |
|
|||||
|
2023
Q2 | $1.33M | Buy |
|
|||||
|
2023
Q1 | $426K | Sell |
|
|||||
|
2022
Q4 | $581K | Sell |
|
|||||
|
2022
Q3 | $1.31M | Sell |
|
|||||
|
2022
Q2 | $1.29M | Buy |
|
|||||
|
2022
Q1 | $1.36M | Buy |
|
|||||
|
2021
Q4 | $1.83M | Sell |
|
|||||
|
2021
Q3 | $2.1M | Buy |
|
|||||
|
2021
Q2 | $2.62M | Buy |
|
|||||
|
2021
Q1 | $969K | Sell |
|
|||||
|
2020
Q4 | $1.76M | Buy |
|
|||||
|
2020
Q3 | $324K | Sell |
|
|||||
|
2020
Q2 | $384K | Sell |
|
|||||
|
2020
Q1 | $351K | Buy |
|